U.S. equities and stock exchange traded funds were stuck in mixed action Monday as hurdles on Capitol Hill stalls President Donald Trump’s policy agenda and traders wait on corporate results.
Observers kept an eye on Washington where Jared Kushner answered questions before a Senate committee as the Trump administration’s agenda hits a roadblock, Bloomberg reports.
Investors are also wary of further surprises out of Washington as the administration faces a widening Russia probe. Kushner confirmed four contacts with Russians during his father-in-law’s presidential campaign and the transition but described it as unmemorable.
The ongoing drama, along with the failed attempt to repeal the Affordable Care Act or so-called Obamacare, have stalled the pro-growth economic agenda that President Trump has promised.
Meanwhile, the earnings season is still in full swing, with market’s slipping in early trading Monday on Johnson & Johnson (NYSE: JNJ) after South Korea’s Samsung Bioepis said it started U.S. sales of the company’s top selling drug Remicade, Reuters reports.